Beyond the basics: rethinking antimicrobial stewardship by targeting cytomegalovirus immune globulin for immunocompromised patients

2025/01/01 by Ritika Prasad, Brian Lu, Daniella Veloria +6 · 1 voice
Medicine · #Cytomegalovirus and herpesvirus research #Herpesvirus Infections and Treatments #Polyomavirus and related diseases

paper · pdf · doi:10.1017/ash.2025.10074

openalex publication_date 2025/01/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/22

Abstract

Identifying actionable stewardship targets in immunocompromised patients is challenging due to limited data and high morbidity. One approach could be targeting therapy with limited evidence, like cytomegalovirus immune globulin (CMV-IGIV). We implemented a drug restriction program that increased appropriate use of CMV-IGIV, highlighting a unique stewardship opportunity in immunocompromised populations.

Discussions

• @ritikaprasad.bsky.social, @stanfordasp.bsky.social, @marisa-holubar.bsky.social et al: Identifying ASP targets in immunocompromised patients is challenging. We implemented a restriction program that [bsky, 3 points, 0 comments]

Related

• Charting new territory: outpatient stewardship in immunocompromised patients (first of a two-part series)
• Adopting prospective antimicrobial stewardship (AMS) practice in high-risk immunosuppressed groups: an urgent call to action in the era of antimicrobial resistance (AMR)
• Provider perceptions of an antimicrobial stewardship program in immunocompromised patients at a cancer center
• The importance of drug exposure in the development of cytomegalovirus resistance
• Antimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health